HSPA5 and breast carcinoma: In glioma cells and breast cancer cells, the inhibition of GRP78 expression improves sensitivity to chemotherapy [115,122]; in particular, in resistant breast cancer cells, it re-establishes sensitivity to anti-oestrogens [119].